Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
36 hedge funds and large institutions have $10.4M invested in Histogen Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 3 closing their positions.
175% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 4
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
74% more call options, than puts
Call options by funds: $200K | Put options by funds: $115K
13% more funds holding
Funds holding: 32 → 36 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less capital invested
Capital invested by funds: $10.5M → $10.4M (-$132K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$71.5K |
| 2 |
Citigroup
New York
|
+$45.5K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$37.7K |
| 4 |
Axa
Paris,
France
|
+$36.7K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$36.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$159K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$74K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$36.2K |
| 4 |
Morgan Stanley
New York
|
-$17.1K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$5.88K |
HSTO Hedge Fund Activity: Q2 2016 in Review
36 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q2 2016, worth a combined $10.4M — down 1.3% from $10.5M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new HSTO positions and 3 closed out — a net gain of 4 holders — while 11 added to existing stakes and 4 trimmed.
The largest buyer was D.E. Shaw & Co, adding an estimated $71.5K. The largest seller was Bridgeway Capital Management, cutting an estimated $159K.
- 36 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q2 2016, up from 32 in Q1 2016.
- Funds reported $10.4M of Histogen Inc. Common Stock stock for Q2 2016, down 1.3% quarter-over-quarter.
- 7 funds opened new Histogen Inc. Common Stock positions in Q2 2016 and 3 closed out, a net change of +4 holders.
- The largest Histogen Inc. Common Stock buyer in Q2 2016 was D.E. Shaw & Co, an estimated $71.5K added.
- The largest Histogen Inc. Common Stock seller in Q2 2016 was Bridgeway Capital Management, an estimated $159K sold.
Based on aggregated 13F filings for Q2 2016.